Main Uses of Metrin (Permethrin)

Metrin, which contains the active ingredient permethrin, is a topical medication primarily used to treat infestations caused by specific parasites that live on or under the human skin. As a pyrethroid, it works by disrupting the nervous system of these organisms, leading to their paralysis and eventual death.

Treatment of Scabies

The primary clinical use of permethrin is for the treatment of scabies, a skin condition caused by the microscopic mite Sarcoptes scabiei. The medication is designed to eliminate both the adult mites and their eggs. By addressing the underlying infestation, it helps resolve the intense itching and skin rash associated with the mites burrowing into the upper layer of the skin.

Treatment of Head Lice

Permethrin is frequently utilized to treat head lice (Pediculus humanus capitis). It is applied to the hair and scalp to target active lice. While it is highly effective at killing live lice, its ability to eliminate unhatched eggs (nits) may vary, sometimes requiring a follow-up application to ensure any newly hatched lice are eradicated.

Treatment of Pubic Lice

This medication is also indicated for the treatment of pubic lice (Pthirus pubis), commonly referred to as crabs. It works through the same mechanism of action, neutralizing the parasites found in the pubic hair and surrounding areas.

Benefits of Treatment

Resolution of Infestation

The most significant benefit of permethrin is its high efficacy rate in clearing parasitic infestations. By eradicating the parasites at all stages of their life cycle, it addresses the root cause of the skin irritation.

Symptom Relief

While the medication itself does not immediately stop itching, the elimination of the parasites allows the skin to begin the healing process. Over time, this leads to the disappearance of the inflammatory response, papules, and tracks caused by the infestation.

Prevention of Secondary Infections

Parasitic infestations often lead to intense scratching, which can break the skin barrier and create an entry point for bacteria. By promptly treating the primary infestation, permethrin helps reduce the risk of secondary bacterial skin infections like impetigo or cellulitis.

Public Health Impact

Effective treatment of the individual serves a broader purpose by breaking the cycle of transmission. Since scabies and lice are highly contagious and spread through close physical contact or shared items, successful treatment helps prevent the further spread of the parasites within households, schools, and communities.

Regulatory References

1. NIH MedlinePlus Drug Information

Who Can and Cannot Use Metrin (Permethrin)?

The eligibility for using Metrin (Permethrin) is defined by official regulatory criteria, primarily based on age, known hypersensitivity, and physiological status.

Populations Approved for Use

The 5% cream is generally approved for patients 2 months of age and older for the treatment of scabies. This includes adults, adolescents, and older adults, with no required dose adjustments or special precautions noted for the geriatric population in most official labeling.

Absolute Contraindications (Must Not Use)

A patient must not use Metrin (Permethrin) if they have a known hypersensitivity or allergy to:

• The active substance, Permethrin.
• Any synthetic pyrethroid or pyrethrin (related compounds).
• Plants of the Asteraceae/Compositae family (e.g., chrysanthemums or ragweed) due to potential cross-reactivity.

Conditional Use and Restrictions

• Infants under 2 months of age: Safety and effectiveness have not been established.
• Infants 2 to 23 months: Treatment in this age group should be given under close medical supervision.
• Pregnancy and Breastfeeding: Use is generally considered low-risk due to minimal systemic absorption, but should only occur after consulting a healthcare professional.

Interactions with other medicines and products

The official regulatory profile for Metrin (Permethrin) dermal preparations indicates a low potential for systemic drug-drug interactions due to the minimal absorption of the active substance into the bloodstream. No clinically relevant systemic metabolic or transporter-mediated interactions with other medicines are documented in prescribing information. The documented constraints primarily focus on localized effects and sequential administration rules.

Local and Product Incompatibility

The excipients (e.g., paraffin, lanolin alcohols) present in the Permethrin cream are officially documented to interact with certain materials. The application of the cream in the anogenital area may damage or reduce the function of latex products, specifically condoms and diaphragms, leading to a potential failure of these barrier methods. This is classified as a physical product incompatibility rather than a systemic medicinal interaction.

Pharmacodynamic and Administration Constraints

A sequential restriction exists concerning the use of corticosteroid preparations. Treatment with topical or systemic corticosteroids for any associated skin reactions should be withheld immediately prior to the Permethrin application. This timing-based constraint prevents pharmacodynamic interference which could suppress the skin's response, potentially masking the underlying infestation and leading to treatment failure. This rule is documented to ensure therapeutic efficacy.

Permethrin functions as a neurotoxin by acting as a selective modulator of the voltage-gated sodium channels (VGSCs) found in the ectoparasite's nerve cell membranes. By binding to these channels, the drug prevents their normal closure (inactivation), causing a sustained and massive influx of sodium ions ( Na^+). This immediate biophysical interference initiates the critical cascade of nerve signaling disruption, leading to sustained neuronal depolarization and uncontrolled hyperexcitability across the entire parasitic nervous system. This complete failure of nerve impulse termination rapidly progresses to systemic paralysis of the organism. This acute loss of motor and physiological function is the direct consequence of the drug's mechanism, which results in the extermination of the external parasite. The efficacy of this specific mechanism is constrained by biological counter-mechanisms, such as Target-Site Resistance (genetic mutations in the VGSCs) and metabolic detoxification, which can prevent the induction of sustained paralysis.

Official Administration and Dosing Principles

Permethrin is administered exclusively via the topical route for external use, utilizing two primary concentrations: a 5% cream for the management of scabies and a 1% lotion or creme rinse for the management of pediculosis (lice). The official administration protocol is structured around a single, time-bound course of therapy.

Application for Scabies (5% Cream)

Scabies treatment generally consists of a single application. The cream must be thoroughly massaged into the entire skin surface, commencing from the head to the soles of the feet. A dose of up to 30 grams is typically used for a single adult application to ensure complete coverage. The preparation must remain on the skin for a contact time ranging between a minimum of 8 hours and a maximum of 14 hours before being removed entirely by washing (showering or bathing).

Application for Lice (1% Lotion)

For lice treatment, one application is the standard course. The 1% lotion must be applied to the hair and scalp, ensuring complete saturation. The product should be left in place for 10 minutes, but no longer, before being rinsed off with warm water. Official use instructions stipulate that the initial shampoo should not contain a conditioner. If live lice are detected after the initial application, a second treatment may be considered seven days or more later.

Age-Specific Procedural Rules

The topical preparations are approved for use in patients two months of age and older. In the pediatric population and older adults, official guidance requires the 5% cream application to specifically encompass the scalp, temples, and forehead to ensure complete parasite clearance.

Permethrin: Recent Clinical Evidence

Core Mechanism Studies

Research has explored whether a specific permethrin formulation could be studied for its relationship with scabies and pediculosis (lice) conditions. Early studies investigated how the drug behaves in laboratory settings, focusing on its known neurotoxic action in arthropods.

Research explored potential links between the drug and changes observed in the nervous system of target parasites. The investigation explored the drug's relationship with parameters related to parasite control over a specific treatment period.

Clinical Trials and Research Focus

Permethrin has been a subject of research examining its use in both the treatment of scabies and various forms of pediculosis, primarily focusing on topical formulations used in pediatric and adult populations.

A randomized controlled trial (RCT) investigated the drug's effects on parasite eradication compared to a placebo group or other topical treatments. The primary endpoint measured was the rate of parasitic clearance or clinical cure after a set number of weeks. Studies reported findings related to this effect, often highlighting the drug's established efficacy when applied correctly.

Safety and Research Suitability

Research explored permethrin's use in various populations to assess study measures over a short duration, including single and repeat applications.

Research reviewed potential safety concerns in individuals with pre-existing skin conditions or known allergies to pyrethrins, as initial data indicated the drug was studied in this population. Studies have also examined the drug's use in various populations, including young children, where adherence to application guidelines is critical for safety and outcome.

Key Studies & References

1. Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed
2. Label: PERMETHRIN- permethrin cream 5% w/w cream - DailyMed

Common questions about Metrin (Permethrin) (FAQ)

Q: What is the main difference between Permethrin 1% and Permethrin 5% cream/lotion?

A: The primary difference is the concentration and the approved use. Official product information states that Permethrin 1% is used to treat head lice, while the higher strength Permethrin 5% is used for the treatment of scabies.

Q: How long after applying Metrin (Permethrin) can I expect the mites/lice to die?

A: Permethrin is described as acting rapidly by causing paralysis and death of the parasites. The official instructions require the product to remain on the affected area for a specific contact time to complete the treatment: 10 minutes for the 1% lotion (lice) and 8 to 14 hours for the 5% cream (scabies).

Q: What if I have severe skin inflammation or an open wound when I need to apply the cream?

A: Official information advises that the cream is for external use only. Since applying the product may temporarily worsen existing symptoms like itching or redness, use on areas of severely damaged or inflamed skin should be approached with caution.

Q: Is it safe to use Metrin (Permethrin) on the scalp or head hair?

A: Yes, Permethrin is used on the scalp and hair under official guidance. The 1% lotion is specifically applied to the hair and scalp for the treatment of lice. For the 5% cream in certain populations, official directions require application to include the scalp, temples, and forehead for scabies.

Q: Is it possible for the itching to last for weeks even if the treatment worked correctly?

A: Yes, regulatory documents indicate that itching (pruritus) can persist for up to four weeks after successful treatment. This is a known, common side effect called post-scabetic pruritus, which often resolves over time.

Q: Can Metrin (Permethrin) be used on infants and young children?

A: Official regulatory information states that the topical preparations are approved for use in the pediatric population. Specifically, the medicine is approved for use in children who are two months of age and older.

Q: If I am breastfeeding, is Metrin (Permethrin) safe for the nursing baby?

A: Regulatory documents indicate the product is addressed for use during breastfeeding due to its low systemic absorption. Public health guidelines often mention Permethrin 5% cream as one option for scabies treatment in this population.

Q: Why is the itching often worse right after I use Metrin (Permethrin) cream?

A: The official drug label notes that the infestation itself often causes underlying symptoms like itching, swelling, and redness. Treatment with the cream may temporarily exacerbate (make worse) these existing skin conditions.

Q: Are there any specific cleaning steps I need to take for my house, bedding, and clothes after using Metrin?

A: Official public health guidance advises that all exposed bedding, clothing, and towels should be decontaminated following treatment. Guidance addresses decontamination measures such as washing materials in a hot water cycle or dry cleaning, or isolating items from contact for a specified duration.

Q: Can pets in the home be treated with the same Metrin (Permethrin) product?

A: Permethrin is a chemical used in various products, including some for animal use. However, the Metrin medicine intended for human use for scabies and lice is not officially approved or labeled for veterinary treatment of pets. Regulatory documents confirm the product is formulated and labeled strictly for use as directed in the human prescribing information.

Q: What is the difference between Permethrin and Ivermectin, which is another treatment for these conditions?

A: Permethrin is classified as a synthetic pyrethroid, which is a topical anti-infective used on the skin. Ivermectin is classified as an anthelmintic, a different class of medicine used in both oral and topical forms. Both agents are used to treat similar parasitic conditions.

Q: Will Metrin (Permethrin) prevent me from catching the infection again in the future?

A: Regulatory indications for the topical preparations are strictly for the treatment of existing infestations (scabies and lice). The product is not approved for use as a preventative measure (prophylaxis).

Q: Can Metrin (Permethrin) cause an allergic reaction, and what signs should I look for?

A: Regulatory documents note the potential for serious reactions, including hypersensitivity reactions and allergic contact dermatitis. Signs of a more severe reaction can include difficulty breathing, significant swelling (of the face, lips, tongue, or throat), or a widespread, severe rash.

Q: How quickly is Metrin (Permethrin) absorbed into the body through the skin?

A: Permethrin is poorly absorbed through the skin. Official data indicates that very small amounts, typically less than 2% of the applied dose, are absorbed. Any absorbed amount is rapidly metabolized into inactive byproducts and excreted primarily in the urine.

Q: Can Metrin (Permethrin) be purchased without a prescription in some concentrations?

A: Permethrin topical preparations are available in both non-prescription and prescription-only formulations. The 1% product is commonly classified for non-prescription purchase, while the 5% cream typically requires a prescription, based on regulatory classifications.

Q: Is it possible to become resistant to the effects of Metrin (Permethrin)?

A: Official information on the drug’s mechanism of action notes that its efficacy can be constrained by biological counter-mechanisms in the parasites. These include metabolic detoxification and Target-Site Resistance, which is caused by genetic mutations in the parasite.

Q: Is Metrin (Permethrin) known to cause temporary discoloration or texture changes on the skin?

A: Officially documented skin side effects include redness (erythema), mild rash, and dry skin. Temporary discoloration or texture changes beyond these effects are not commonly listed as documented adverse reactions in official prescribing information.

Q: Does Metrin (Permethrin) have any known interaction with herbal supplements or dietary products?

A: Regulatory information indicates that due to minimal absorption into the bloodstream, the potential for clinically relevant systemic interactions is considered low. This applies to interactions with other medicines, herbal supplements, or dietary products.

Q: Can using Metrin (Permethrin) make existing skin conditions, like eczema, temporarily worse?

A: Official warnings indicate that treatment may temporarily exacerbate existing skin conditions, including associated itching, swelling, or redness. This effect is often considered a normal response to the underlying infestation and the drug's action.

Q: Is Metrin (Permethrin) an antibiotic, a steroid, or a different type of medicine?

A: Permethrin is officially classified as a synthetic pyrethroid and a topical anti-infective. It functions as a neurotoxin specifically targeting ectoparasites and is neither classified as an antibiotic nor a steroid.

Q: Can Metrin (Permethrin) be used for conditions other than scabies or lice, such as bug bites?

A: The officially approved indications for Metrin (Permethrin) topical preparations are strictly for the treatment of infestations with Sarcoptes scabiei (scabies) and Pediculus humanus capitis (lice).

Q: Is there a maximum number of times Metrin (Permethrin) can be used within a specific time period?

A: Official administration instructions describe the course as a single application, with the possibility of a second treatment seven days or more later if live parasites are detected. Regulatory documents do not define a specific maximum lifetime or yearly use limit beyond the specified retreatment guidance.

Q: What kind of sensation is normal to feel on the skin immediately after applying the cream?

A: Common sensations reported often at the beginning of treatment include mild and temporary tingling (paresthesia), burning, or stinging. These are officially documented local effects.

Q: Is it necessary to treat all family members at the same time, even if they don't have symptoms?

A: Official public health guidelines for controlling infestations often recommend that household members and close contacts of the infested individual be treated simultaneously. The guidance is based on public health protocols designed to address potential reinfestation among close contacts and household members.

How to Store and Dispose of Metrin (Permethrin) Cream 5%

Permethrin cream must be stored at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F), and should be kept away from excess heat and moisture.

Storage and Handling

• Do not freeze the cream, as this can affect its stability.
• Keep the product in the container it came in, tightly closed.
• The medication must be stored out of the sight and reach of children.
• Materials contaminated with the cream (e.g., bedding) must be kept away from a naked flame due to increased flammability risk.

Disposal Instructions

• Discard any remaining contents after use according to local regulatory requirements (e.g., drug take-back programs).
• Do not dispose of the product by throwing it into wastewater or drains, as Permethrin is toxic to aquatic life.